237
Participants
Start Date
March 6, 2013
Primary Completion Date
June 18, 2015
Study Completion Date
May 20, 2016
GSK 1437173A
2 doses administered by intramuscular (IM) injection into the deltoid muscle of the non-dominant arm.
Placebo
2 doses administered by IM injection into the deltoid muscle of the non-dominant arm.
GSK Investigational Site, Badajoz
GSK Investigational Site, Besançon
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Majadahonda (Madrid)
GSK Investigational Site, Pozuelo de Alarcón/Madrid
GSK Investigational Site, San Sebastián de los Reyes
GSK Investigational Site, Móstoles
GSK Investigational Site, Nîmes
GSK Investigational Site, Lyon
GSK Investigational Site, Férolles-Attilly
GSK Investigational Site, Halifax
GSK Investigational Site, Toronto
GSK Investigational Site, Montreal
GSK Investigational Site, Prague
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Barcelona
GSK Investigational Site, Cheltenham
GSK Investigational Site, Woolwich
GSK Investigational Site, Swindon
GSK Investigational Site, Exeter
GSK Investigational Site, Sheffield
GSK Investigational Site, York
Lead Sponsor
GlaxoSmithKline
INDUSTRY